Tramadol vs morphine during adenotonsillectomy for obstructive sleep apnea in children

Paediatric Anaesthesia - Tập 16 Số 6 - Trang 648-653 - 2006
Bruce Hullett1, NEIL A. CHAMBERS1, Elaine M. Pascoe1, Chris Johnson1
1Department of Anaesthesia and Pain Management, Princess Margaret Hospital for Children, Perth, WA, Australia

Tóm tắt

SummaryBackground:  Optimal analgesia for children undergoing adenotonsillectomy for obstructive sleep apnea (OSA) is controversial. Tramadol may represent a superior choice over morphine in this group, with a potential to cause less postoperative sedation and respiratory depression. Optimal perioperative analgesia may allow expensive and time‐consuming preoperative work‐up and postoperative monitoring to be rationalized.Methods:  Sixty‐six children were randomized to receive either perioperative tramadol or morphine in this double blinded, prospective, controlled trial. Postoperative sedation, pain, respiratory events, and vomiting were then compared between groups.Results:  There was no significant difference between the two groups in sedation scores 1 h after arrival in recovery (P = 0.24) or at any other time up to 6 h postoperation. There was also no evidence of a difference between the groups in pain scores up to 6 h postoperation. There were fewer episodes of postoperative desaturation (<94%) in the tramadol group up to 3 h postoperation, with 26% fewer episodes in the tramadol group during the second hour postoperation (P = 0.02). Overall, there was a trend toward fewer desaturation episodes in the tramadol group.Conclusions:  Tramadol may be a suitable drug for children undergoing adenotonsillectomy for OSA. Further work is required to investigate this.

Từ khóa


Tài liệu tham khảo

10.1213/00000539-200301000-00015

10.1046/j.1460-9592.2003.00983.x

10.1136/bmj.2.5920.656

Robertson J, 1993, Pediatric pain assessment: validation of a multidimensional tool, Pediatr Nurs, 19, 209

10.1001/archotol.1992.01880090056017

Grundfast K, 1990, Outcome and complications following surgery for obstructive adenotonsillar hypertrophy in children with neuromuscular disorders, Ear Nose Throat J, 69, 756

10.1001/archotol.1996.01890200003001

10.1001/archotol.1997.01900050067009

10.1001/archotol.124.2.171

10.1097/00000542-200202000-00015

10.1097/00004691-199605000-00003

10.1378/chest.108.3.610

10.1097/00000542-200404000-00009

10.1177/0310057X0002800403

10.1007/BF03018549

10.1111/j.1460-9592.2004.01516.x